Cosmo Pharmaceuticals N.V. (LON:0RGI)
London · Delayed Price · Currency is GBP · Price in CHF 67.29
-0.21 (-0.31%)
At close: Nov 3, 2025
Cosmo Pharmaceuticals Market Cap
Cosmo Pharmaceuticals has a market cap or net worth of 968.91 million as of November 5, 2025. Its market cap has decreased by -7.51% in one year.
Market Cap
968.91M
Enterprise Value
865.44M
Revenue
156.24M
Ranking
n/a
PE Ratio
18.84
Stock Price
67.29
Market Cap Chart
Since March 12, 2007, Cosmo Pharmaceuticals's market cap has increased from 82.45M to 968.91M, an increase of 1,075.17%. That is a compound annual growth rate of 14.11%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Nov 5, 2025 | 968.91M | 7.59% |
| Dec 30, 2024 | 900.54M | 18.04% |
| Dec 29, 2023 | 762.90M | -15.23% |
| Dec 30, 2022 | 899.97M | 0.53% |
| Dec 30, 2021 | 895.23M | -12.52% |
| Dec 30, 2020 | 1.02B | 16.03% |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2015 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| AstraZeneca | 194.27B |
| GSK plc | 71.94B |
| Haleon | 31.88B |
| Smith & Nephew | 12.02B |
| ConvaTec Group | 4.86B |
| Hikma Pharmaceuticals | 3.90B |
| HUTCHMED (China) | 2.01B |
| Genus | 1.65B |